ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 133 filers reported holding ANIKA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,116,573 | -27.4% | 113,611 | +1.2% | 0.00% | 0.0% |
| Q2 2023 | $2,916,229 | -8.1% | 112,249 | +1.6% | 0.00% | 0.0% |
| Q1 2023 | $3,173,532 | -3.5% | 110,499 | -0.6% | 0.00% | 0.0% |
| Q4 2022 | $3,290,307 | +26.8% | 111,159 | +2.0% | 0.00% | 0.0% |
| Q3 2022 | $2,595,000 | +11.7% | 109,007 | +4.7% | 0.00% | 0.0% |
| Q2 2022 | $2,323,000 | -11.2% | 104,072 | -0.1% | 0.00% | 0.0% |
| Q1 2022 | $2,616,000 | -28.1% | 104,150 | +2.5% | 0.00% | 0.0% |
| Q4 2021 | $3,640,000 | -15.8% | 101,570 | +0.0% | 0.00% | 0.0% |
| Q3 2021 | $4,323,000 | +0.2% | 101,565 | +1.9% | 0.00% | 0.0% |
| Q2 2021 | $4,314,000 | -10.8% | 99,648 | -16.0% | 0.00% | -50.0% |
| Q1 2021 | $4,837,000 | -5.9% | 118,567 | +4.4% | 0.00% | 0.0% |
| Q4 2020 | $5,140,000 | +28.0% | 113,551 | +0.1% | 0.00% | 0.0% |
| Q3 2020 | $4,015,000 | -6.5% | 113,431 | -0.3% | 0.00% | 0.0% |
| Q2 2020 | $4,292,000 | +28.5% | 113,748 | -1.5% | 0.00% | 0.0% |
| Q1 2020 | $3,341,000 | -46.7% | 115,538 | -4.5% | 0.00% | -33.3% |
| Q4 2019 | $6,273,000 | -3.0% | 120,966 | +2.7% | 0.00% | -25.0% |
| Q3 2019 | $6,466,000 | +69.6% | 117,787 | +25.5% | 0.00% | +100.0% |
| Q2 2019 | $3,812,000 | +55.7% | 93,844 | +15.9% | 0.00% | 0.0% |
| Q1 2019 | $2,448,000 | -5.9% | 80,949 | +4.6% | 0.00% | 0.0% |
| Q4 2018 | $2,602,000 | -25.1% | 77,397 | -6.0% | 0.00% | 0.0% |
| Q3 2018 | $3,474,000 | +37.5% | 82,343 | +4.3% | 0.00% | 0.0% |
| Q2 2018 | $2,526,000 | -33.5% | 78,929 | +3.3% | 0.00% | -33.3% |
| Q1 2018 | $3,798,000 | +2.8% | 76,385 | +11.4% | 0.00% | 0.0% |
| Q4 2017 | $3,696,000 | -3.3% | 68,551 | +4.1% | 0.00% | 0.0% |
| Q3 2017 | $3,821,000 | +10.2% | 65,865 | -6.3% | 0.00% | 0.0% |
| Q2 2017 | $3,468,000 | +23.1% | 70,279 | +8.4% | 0.00% | 0.0% |
| Q1 2017 | $2,817,000 | -6.3% | 64,843 | +5.5% | 0.00% | 0.0% |
| Q4 2016 | $3,008,000 | +21.8% | 61,435 | +19.0% | 0.00% | 0.0% |
| Q3 2016 | $2,470,000 | +73.6% | 51,617 | +94.7% | 0.00% | +50.0% |
| Q2 2016 | $1,423,000 | +20.0% | 26,506 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $1,186,000 | -69.7% | 26,506 | -74.1% | 0.00% | -60.0% |
| Q4 2015 | $3,908,000 | +14.0% | 102,406 | -4.9% | 0.01% | 0.0% |
| Q3 2015 | $3,427,000 | -30.4% | 107,659 | -27.8% | 0.01% | -28.6% |
| Q2 2015 | $4,924,000 | -19.8% | 149,076 | 0.0% | 0.01% | -22.2% |
| Q1 2015 | $6,138,000 | +1.1% | 149,076 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $6,074,000 | +43.9% | 149,076 | +29.5% | 0.01% | +28.6% |
| Q3 2014 | $4,221,000 | -12.2% | 115,114 | +11.0% | 0.01% | -12.5% |
| Q2 2014 | $4,805,000 | -18.3% | 103,710 | -27.5% | 0.01% | -27.3% |
| Q1 2014 | $5,879,000 | +10.4% | 143,030 | +2.5% | 0.01% | +10.0% |
| Q4 2013 | $5,325,000 | +71.1% | 139,530 | +11.7% | 0.01% | +66.7% |
| Q3 2013 | $3,113,000 | +1007.8% | 124,930 | +671.2% | 0.01% | +500.0% |
| Q2 2013 | $281,000 | – | 16,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Trigran Investments, Inc. | 1,154,183 | $25,761,000 | 3.00% |
| CAPITAL MANAGEMENT CORP /VA | 275,130 | $6,141,000 | 1.52% |
| Kent Lake Capital LLC | 98,570 | $2,200,000 | 1.21% |
| DIKER MANAGEMENT LLC | 21,835 | $487,000 | 0.60% |
| Portolan Capital Management | 235,972 | $5,267,000 | 0.53% |
| Riverwater Partners LLC | 12,466 | $278,000 | 0.28% |
| Ranger Investment Management | 139,661 | $3,117,000 | 0.24% |
| Invenomic Capital Management LP | 144,287 | $3,220,000 | 0.23% |
| CHATHAM CAPITAL GROUP, INC. | 23,787 | $531,000 | 0.12% |
| Teton Advisors, Inc. | 22,000 | $491,000 | 0.10% |